surmount-1 tirzepatide weight loss non-diabetic trial Tirzepatide for Obesity: Highlights from the SURMOUNT-1 SURMOUNT-1

Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Dermody SS, Prince MA, Jordan R, McKee SA, Fletcher PJ, Claus ED, Klein KR

In 2025, medications like Wegovy, semaglutide, and tirzepatide are leading the way for individuals seeking physician-guided support in their weight management journey

Daniel Rosen suggested that Ozempic poo might be caused by your bodys alert system: When you eat a large meal, there's something called the gastrocolic reflex, where the stretch in the top of the stomach alerts the very end of the colon and rectum to empty." He went on to say that GLP-1 medications like Ozempic and Wegovy can "trick your brain into thinking that food has arrived to the end of the intestines." Speaking to LADBible Group, Novo Nordisk shared the following statement: "Gastrointestinal (GI) events are well-known side effects of the GLP-1RA class

GLP-1 RAs and dual GIP/GLP-1 agonists exert favorable effects on inflammation, endothelial function, and lipoprotein metabolism, some of which extend beyond weight loss alone [73]

Klinic includes full prior authorization support as a mainstay of care

These side effects are dose-dependent and typically improve with time and proper dose titration